3irk

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (10:06, 21 February 2024) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
==Solution Structure of Heparin dp30==
==Solution Structure of Heparin dp30==
-
<StructureSection load='3irk' size='340' side='right' caption='[[3irk]]' scene=''>
+
<StructureSection load='3irk' size='340' side='right'caption='[[3irk]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[3irk]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IRK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3IRK FirstGlance]. <br>
+
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3IRK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3IRK FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=IDS:2-O-SULFO-ALPHA-L-IDOPYRANURONIC+ACID'>IDS</scene>, <scene name='pdbligand=SGN:N,O6-DISULFO-GLUCOSAMINE'>SGN</scene></td></tr>
+
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3irk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3irk OCA], [https://pdbe.org/3irk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3irk RCSB], [https://www.ebi.ac.uk/pdbsum/3irk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3irk ProSAT]</span></td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1hpn|1hpn]], [[3iri|3iri]], [[3irj|3irj]], [[3irl|3irl]]</td></tr>
+
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3irk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3irk OCA], [http://pdbe.org/3irk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3irk RCSB], [http://www.ebi.ac.uk/pdbsum/3irk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3irk ProSAT]</span></td></tr>
+
</table>
</table>
-
<div style="background-color:#fffaf0;">
 
-
== Publication Abstract from PubMed ==
 
-
The anionic polysaccharides heparin and heparan sulphate play essential roles in the regulation of many physiological processes. Heparin is often used as an analogue for heparan sulphate. Despite knowledge of an NMR solution structure and 19 crystal structures of heparin-protein complexes for short heparin fragments, no structures for larger heparin fragments have been reported up to now. Here, we show that solution structures for six purified heparin fragments dp6-dp36 (where dp stands for degree of polymerisation) can be determined by a combination of analytical ultracentrifugation, synchrotron X-ray scattering, and constrained modelling. Analytical ultracentrifugation velocity data for dp6-dp36 showed sedimentation coefficients that increased linearly from 1.09 S to 1.84 S with size. X-ray scattering of dp6-dp36 gave radii of gyration R(G) that ranged from 1.33 nm to 3.12 nm and maximum lengths that ranged from 3.0 nm to 12.3 nm. The higher resolution of X-ray scattering revealed an increased bending of heparin with increased size. Constrained molecular modelling of 5000 randomised heparin conformers resulted in 9-15 best-fit structures for each of dp18, dp24, dp30, and dp36 that indicated flexibility and the presence of short linear segments in mildly bent structures. Comparisons of these solution structures with crystal structures of heparin-protein complexes revealed similar ranges of phi (phi) and psi (psi) angles between iduronate and glucosamine rings. We conclude that heparin in solution has a semi-rigid and extended conformation that is preformed for its optimal binding to protein targets without major conformational changes.
 
- 
-
Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes.,Khan S, Gor J, Mulloy B, Perkins SJ J Mol Biol. 2010 Jan 22;395(3):504-21. Epub 2009 Nov 3. PMID:19895822<ref>PMID:19895822</ref>
 
- 
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 
-
</div>
 
-
<div class="pdbe-citations 3irk" style="background-color:#fffaf0;"></div>
 
-
== References ==
 
-
<references/>
 
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Bos taurus]]
+
[[Category: Large Structures]]
-
[[Category: Gor, J]]
+
[[Category: Gor J]]
-
[[Category: Khan, S]]
+
[[Category: Khan S]]
-
[[Category: Mulloy, B]]
+
[[Category: Mulloy B]]
-
[[Category: Perkins, S J]]
+
[[Category: Perkins SJ]]
-
[[Category: Carbohydrate]]
+
-
[[Category: Oligosaccharide]]
+
-
[[Category: X-ray scattering]]
+

Current revision

Solution Structure of Heparin dp30

PDB ID 3irk

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools